Research
Print page Print page
Switch language
Bispebjerg Hospital - a part of Copenhagen University Hospital
Published

Quality of life in patients with skeletal metastases of prostate cancer and status prior to start of endocrine therapy: results from the Scandinavian Prostate Cancer Group Study 5

Research output: Contribution to journalJournal articleResearchpeer-review

  1. National incidence and survival of patients with non-invasive papillary urothelial carcinoma: a Danish population study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Surgical interventions for nephrolithiasis in ankylosing spondylitis and the general population

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Testicular torsion: a follow-up study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Reversible bladder denervation in acute polyradiculitis

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Compensatory renal hypertrophia in patients undergoing unilateral nephrectomy

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Scandinavian Prostate Cancer Group Study 5 Study Group
View graph of relations

OBJECTIVES: Prostate cancer (PC) is a highly lethal neoplastic disease affecting the physical, mental and social well-being of patients, i.e. their quality of life (QOL). Patients suffering from metastatic PC are faced with serious decisions regarding treatment strategies. Therefore, QOL information has become a crucial element of decision making in this group of patients. The first objective of this study was to describe QOL in a group of patients diagnosed with metastatic PC and skeletal metastases. At the time of evaluation the patients had not received any treatment but were evaluated before entering a study of androgen-modulating therapy (the Scandinavian Prostate Cancer Group study 5). The second objective was to identify demographic and disease-related factors affecting QOL.

MATERIAL AND METHODS: A total of 917 patients with metastatic PC were evaluated using a well-described and validated questionnaire [European Organization for Research and Treatment of Cancer Quality-of-Life Questionnaire-C30 (EORTC QLQ-C30)]. The characteristics of the PC were noted, and simultaneously patients were evaluated with respect to use of analgesics, pain and performance status using a scoring system. Biochemical tests were performed when patients entered the study. A multivariate regression analysis was performed to analyse the correlations between QOL scores, patient demographics and disease-related data.

RESULTS: The patients reported QOL scores significantly lower than those in the background population. Pain and fatigue were pronounced, whereas dyspnoea, insomnia, loss of appetite, constipation and diarrhoea were less prominent. Patients with high tumour grades, high PSPA scores (the sum of the pain score, the performance status and the use of analgesics) and those using analgesics had significantly lower QOL scores than the other patients.

CONCLUSIONS: Patients with metastatic PC have reduced QOL. Our findings are in line with those of other studies of QOL among patients with this disease as evaluated by means of the EORTC QLQ-C30 questionnaire. Baseline data from studies like this provide important information when treatment modalities for PC are evaluated.

Original languageEnglish
JournalScandinavian Journal of Urology and Nephrology
Volume39
Issue number1
Pages (from-to)42-8
Number of pages7
ISSN0036-5599
DOIs
Publication statusPublished - 2005

    Research areas

  • Aged, Bone Neoplasms/drug therapy, Estradiol/analogs & derivatives, Estrogens/therapeutic use, Health Status, Humans, Male, Prospective Studies, Prostatic Neoplasms/pathology, Quality of Life, Regression Analysis, Surveys and Questionnaires

ID: 61361467